Edward Hospital, Three Individuals Named in Pro Se Class Action Filed in Kentucky
Last Updated on May 8, 2018
Humana Financial Recovery & Subrogation v. Edward Hospital et al.
Filed: November 7, 2017 ◆§ 3:17-cv-00669-GNS
A lawsuit filed pro se makes a host of allegations against Edward Hospital and three individuals, including two doctors.
An Illinois man has filed a proposed class action lawsuit pro se (without legal representation) on behalf of Humana Financial Recovery & Subrogation against Edward Hospital, two of its doctors and one other individual. Filed in Kentucky, the three-page lawsuit lays out allegations from the plaintiff that during a hip surgery the man underwent on January 30, 2013, the defendants “covertly” installed a “sham prosthesis” that has now failed. Tied into the saga in the complaint is the plaintiff’s supposed $40 million-plus irrevocable trust estate, which the man claims the defendants used to “hire assassins as was perpetrated on January 30th, 2013, by an ‘imposter male nurse,’ who injected a solution into [the plaintiff’s] IV.” The lawsuit goes on to say the plaintiff was “only saved by the Head Nurse conversing with [the plaintiff], who called a ‘RAPID RESPONSE Team,’ then a [CODE BLUE] for resuscitation.”
The plaintiff goes on to allege in the disjointed lawsuit that he was “denied all due process” through oppression and intimidation tactics implemented by the FBI’s special agent-in-charge of a previous criminal case filed by the plaintiff. The four counts specified in the complaint allege RICO violations and civil conspiracy; failure by the defendant Hospital to secure its premises from “hostile actors"; conspiracy and deprivation of the plaintiff’s rights under color of law; and breach of contract and fiduciary duty for surgical services.
Hair Relaxer Lawsuits
Women who developed ovarian or uterine cancer after using hair relaxers such as Dark & Lovely and Motions may now have an opportunity to take legal action.
Read more here: Hair Relaxer Cancer Lawsuits
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.